Recombinant follicle stimulating hormone

Human Reproduction

Volumn 14, Issue 6, 1999, Pages 1418-1419

  Bergh, Christina ^a  

^a University Hospital   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; RECOMBINANT PROTEIN;

FEMALE; FERTILIZATION IN VITRO; HUMAN; PREGNANCY; REVIEW; URINE;

FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; PREGNANCY; RECOMBINANT PROTEINS;

EID: 0033144425     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/14.6.1418     Document Type: Article

References (13)

1. Albano, C., Smitz, J., Camus, M. et al. (1996) Pregnancy and birth in an in-vitro fertilization cycle after controlled ovarian stimulation in a woman with a history of allergic reaction to human menopausal gonadotrophin. Hum. Reprod., 11, 1632-1634.
2. Bergh, C., Howles, C., Borg, K. et al. (1997) Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques. Hum. Reprod., 12, 2133-2139.
3. Devroey, P., Tournaye, H., Van Steirteghem, A. et al. (1998) The use of a 100 IU starting dose of recombinant follicle stimulating hormone (Puregon) in in-vitro fertilization. Hum. Reprod., 13, 565-566.
4. Frydman, R., Avril, C., Camier, B. et al. (1998) A double-blind, randomized study comparing the efficacy of recombinant human follicle stimulating hormone (rhFSH/Gonal-F) and highly purified FSH (uhFSHAletrodin HP) in inducing superovulation in women undergoing assisted reproductive techniques. Hum. Reprod., 13 (Abstr. Book), 94.
5. Mannaerts, B.M.L.L., Rombout, F., Out, H.J. and Coelingh Bennink, H. (1996) Clinical profiling of recombinant follicle stimulating hormone (rFSH; Puregon):relationship between serum FSH and efficacy. Hum. Reprod. Update, 2, 153-161.
6. Out, H.J., Mannaerts, B.M.J.L., Driessen, S.G.A.J. et al. (1996) A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. Hum. Reprod., 10, 2534-2540.
7. Reader, S.C.J., Robertson, W.R. and Diczfalusy, E. (1983) Microheterogeneity of luteinizing hormone in pituitary glands from women of pre and postmenopausal age. Clin. Endocrinol., 19, 355-363.
8. Redfeam, A., Hughes, E.G., O'Connor, M. et al. (1995) Delayed-type hypersensitivity to human gonadotropin:case report. Fertil. Steril., 64, 855-856.
9. Steelman, S.L. and Pohley, F.M. (1953) Assay of the follicle stimulating hormone based on the agumentation with human chorionic gonadotropin. Endocrinology, 53, 604-616.
10. Storring, P.L. (1992) Assaying glycoprotein hormones-influence of glycosylation on immunoreactivity. Trends Biotechnol., 10, 427-431.
11. Wide, L. (1985) Median charge and charge heterogeneity of human pituitary FSH, LH and TSH II. Relationship between sex and age. Acta Endocrinol., 109, 190-197.
12. Wide, L. and Bakos, O. (1993) More basic forms of both human follicle stimulating hormone and Tuteinizing hormone at mid-cycle compared with the follicular and luteal phase. J. Clin. Endocrinol. Metab., 76, 885-889.
13. Wilson, C.A., Leigh, A.J. and Chapman, A.J. (1990) Gonadotrophin glycosylation and function. J. Endocrinol., 125, 3-14.